A platinum-gold nanorod@MOF composite material and its preparation method and application
Through the preparation of platinum-gold nanorod @MOF composite materials, combined with photothermal and Fenton effects, the problem of lack of materials with both photothermal and photodynamic properties in the prior art for tumor suppression is solved, and efficient cancer treatment is achieved and exhibit excellent performance in stability and drug release.
Patent Information
- Application Number
- CN202211685992.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-12-27
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2042-12-27
AI Technical Summary
No materials with photothermal and photodynamic properties and Fenton effects are used to inhibit tumors in the prior art, and traditional cancer treatment methods have problems such as drug resistance, high damage to normal cells, high recurrence rate, and low treatment efficiency.
The platinum-gold nanorod @MOF composite material was used to prepare gold nanorods by seed growth method, and the MOF structure was assembled in situ on its surface, combining plasma-induced electron hole distribution of platinum-gold nanorods and catalytic Fenton Reactions to achieve photothermal and Fenton effects in the NIR-II zone, used for photothermal and chemical kinetics to treat cancer.
The platinum-gold nanorod @MOF composite material is effectively absorbed by laser in the NIR-II area, catalyzing the production of oxygen and toxic free radicals, effectively inhibiting cancer cells, and is stable in a normal physiological environment. It is suitable for drug delivery and controllable release, improving Cancer treatment efficiency.
Smart Images

Figure CN115998865B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of new materials, and specifically relates to a platinum-gold nanorod@MOF composite material with NIR-II region photothermal and Fenton effects, and a preparation method and application thereof. Background Art
[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.
[0003] Cancer is considered one of the most serious diseases faced by human beings. Traditional treatment methods such as surgery, radiotherapy, chemotherapy, etc. have their inherent limitations, such as easy to produce multi-drug resistance, great damage to normal cells, high recurrence rate, low treatment efficiency, etc. With the in-depth study of the characteristics of nanoparticles, advanced cancer treatment strategies based on nanotechnology, such as photothermal therapy, photodynamic therapy, chemodynamic therapy, etc., have become possible, bringing new ideas and methods to tumor treatment.
[0004] Metal-organic frameworks (MOFs) are a new type of self-assembled porous materials with metal connection points and organic bridging ligands. Due to their various unique advantages, such as porosity, high specific surface area, structural and functional diversity, biocompatibility and biodegradability, they have been widely studied for potential biomedical applications in various fields. On the other hand, the large number of metal centers of the framework can be directly used to catalyze the Fenton reaction, and the large specific surface area can promote the full contact between the reactants and the catalyst, thereby promoting the production of reactive oxygen species (ROS) and inhibiting tumors. However, there are no materials that have both photothermal and photodynamic properties and Fenton effect for tumor inhibition. Summary of the invention
[0005] In order to solve the deficiencies of the prior art, the object of the present invention is to provide a platinum-gold nanorod@MOF composite material with NIR-II region photothermal and Fenton effect, and a preparation method and application thereof.
[0006] In order to achieve the above object, the technical solution of the present invention is:
[0007] On the one hand, a method for preparing a platinum-gold nanorod@MOF composite material comprises the following steps:
[0008] (1) preparing gold nanorods by a seed growth method, wherein an ascorbic acid solution, a platinum salt solution and dilute hydrochloric acid are sequentially added to the obtained gold nanorods, the mixture is evenly mixed and then allowed to stand in a water bath overnight to obtain platinum-gold nanorods;
[0009] (2) washing the platinum-gold nanorods by centrifugation, dispersing them in methanol, adding a methanol solution of ferric chloride hexahydrate and stirring vigorously, and then adding a ligand solution and continuing to stir; heating the mixture to react, and collecting the product by centrifugation after the reaction is completed, thereby obtaining a platinum-gold nanorod@MOF composite material.
[0010] On the other hand, the platinum-gold nanorods@MOF composite material prepared by the above-mentioned preparation method of the platinum-gold nanorods@MOF composite material.
[0011] Thirdly, the above-mentioned platinum-gold nanorods@MOF composite material is used in the preparation of photothermal and chemodynamic synergistic treatment of cancer-related drugs.
[0012] The beneficial effects of the present invention are:
[0013] 1. The present invention uses gold nanorods as the matrix, uses adjustable components and morphology structures, rationally designs and derives platinum-gold nanorod heterostructures with high-efficiency near-infrared II region absorption, and in-situ assembles a MOF structure with Fenton effect on its surface, providing a new design idea for nano-therapeutic agents. At the same time, the preparation process of the platinum-gold nanorod@MOF composite material of the present invention is simple, the conditions are mild, and the requirements for instruments and equipment are small.
[0014] 2. The present invention selects platinum-gold nanorods as photothermal agents. On the one hand, the platinum-gold nanorod heterostructure has a more efficient plasma-induced electron-hole distribution, thus exhibiting excellent photothermal performance; on the other hand, platinum nanoparticles can catalyze endogenous hydrogen peroxide in tumors to produce oxygen, thereby overcoming the poor treatment effect caused by tumor hypoxia.
[0015] 3. The platinum-gold nanorod@MOF composite material prepared by the present invention has intrinsic peroxidase mimicking activity, which can effectively convert endogenous H2O2 into toxic hydroxyl radicals to kill cancer cells. It is stable in normal physiological environment, but can be degraded in tumor microenvironment with higher phosphate concentration, and can be used for drug loading and controlled release. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.
[0017] Figure 1 This is a scanning electron microscope image of the platinum-gold nanorod@MOF composite material prepared in Example 1 of the present invention;
[0018] Figure 2 X-ray diffraction patterns of MOF, platinum-gold nanorods, and platinum-gold nanorods@MOF composite materials prepared in Example 1 of the present invention;
[0019] Figure 3 The temperature-time curve of the platinum-gold nanorod@MOF composite material prepared in Example 1 of the present invention under 1064nm laser irradiation;
[0020] Figure 4 This is a time-dependent absorbance (655 nm) variation diagram of the platinum-gold nanorod@MOF composite material prepared in Example 1 of the present invention catalyzing TMB oxidation in the presence of hydrogen peroxide;
[0021] Figure 5 The cytotoxicity of the platinum-gold nanorods@MOF composite material prepared in Example 1 of the present invention after incubation with tumor cells for different time periods. DETAILED DESCRIPTION
[0022] In view of the fact that there are currently no reports on materials having both photothermal and photodynamic properties and Fenton effect for inhibiting tumors, the present invention proposes a platinum-gold nanorod@MOF composite material and a preparation method and application thereof.
[0023] A typical embodiment of the present invention provides a method for preparing a platinum-gold nanorod@MOF composite material, comprising the following steps:
[0024] (1) preparing gold nanorods by a seed growth method, wherein an ascorbic acid solution, a platinum salt solution and dilute hydrochloric acid are sequentially added to the obtained gold nanorods, the mixture is evenly mixed and then allowed to stand in a water bath overnight to obtain platinum-gold nanorods;
[0025] (2) washing the platinum-gold nanorods by centrifugation, dispersing them in methanol, adding a methanol solution of ferric chloride hexahydrate and stirring vigorously, and then adding a ligand solution and continuing to stir; heating the mixture to react, and collecting the product by centrifugation after the reaction is completed, thereby obtaining a platinum-gold nanorod@MOF composite material.
[0026] In some examples of this implementation mode, the seed growth method is specifically:
[0027] Adding chloroauric acid solution to hexadecyltrimethylammonium bromide (CTAB) solution, then quickly adding glacial sodium borohydride solution, and aging at room temperature to obtain a seed solution;
[0028] In the mixed solution of CTAB and stabilizer, silver nitrate solution and chloroauric acid solution are added successively, and after being stirred evenly, ascorbic acid solution is added to obtain a growth solution;
[0029] The seed solution was added to the growth solution and allowed to stand overnight at room temperature to obtain gold nanorods.
[0030] Gold nanorods (AuNRs) have attracted extensive attention due to their highly tunable morphology, unique anisotropic plasmonic properties, and widely tunable plasmon wavelength, becoming an important protagonist in innovative tumor diagnosis and treatment methods.
[0031] Wherein, in the seed solution, the concentration of the CTAB solution is 0.1-0.5M, preferably 0.1M.
[0032] The concentration of the chloroauric acid solution is 0.01-0.05M, preferably 0.01M.
[0033] The concentration of the sodium borohydride solution is 0.01-0.05M, preferably 0.01M.
[0034] Preferably, the volume of CTAB solution, chloroauric acid solution and sodium glacial borohydride solution is 10:0.2-0.5:0.5-1.0.
[0035] Wherein, in the growth solution, the CTAB concentration in the mixed solution of CTAB and stabilizer is 30-50 mg / mL, and the stabilizer concentration is 3-5 mg / mL. Preferably, the stabilizer is sodium oleate, 5-bromosalicylic acid, 2,6-dihydroxybenzoic acid or 4-methylsalicylic acid.
[0036] The concentration of the silver nitrate solution is 0.01-0.05M, preferably 0.01M.
[0037] The concentration of the chloroauric acid solution is 1-5 mM, preferably 1 mM.
[0038] The concentration of the ascorbic acid solution is 0.1-0.5M, preferably 0.1M.
[0039] Preferably, the volume ratio of the mixed solution of CTAB and stabilizer to the silver nitrate solution, the chloroauric acid solution, and the ascorbic acid solution is 100:1-5:100:0.1-0.7.
[0040] Wherein, the volume ratio of the silver nitrate solution to the seed solution is 7.5-10.5:1.
[0041] Due to the synergistic effect between noble metals, bimetallic heterostructures composed of two noble metals have attracted attention. Pt-Au bimetallics have many unique properties, and Pt-Au heterostructures exhibit excellent photothermal and photodynamic performance due to more efficient plasma-induced electron-hole distribution.
[0042] In some examples of this embodiment, the concentration of the ascorbic acid solution is 0.1-0.5M, preferably 0.1M.
[0043] In some examples of this embodiment, the platinum salt is chloroplatinic acid, potassium chloroplatinate or potassium chloroplatinite; preferably, the concentration of the platinum salt solution is 0.01-0.03M, preferably 0.01M.
[0044] In some examples of this embodiment, the concentration of the dilute hydrochloric acid is 0.01-0.05M, preferably 0.01M.
[0045] In some examples of this embodiment, the volume ratio of gold nanorods to ascorbic acid solution, platinum salt solution, and dilute hydrochloric acid solution is 10: 0.2-2: 0.01-0.2: 0.01-0.1.
[0046] In some examples of this embodiment, the water bath has a temperature of 27°C-33°C, preferably 27°C, 28°C, 30°C, or 33°C.
[0047] In some examples of this embodiment, the ligand is 2-aminoterephthalic acid or trimesic acid; preferably, the concentration of the ligand solution is 5-10 mM.
[0048] In some examples of this embodiment, the concentration of the ferric chloride hexahydrate methanol solution is 5-10 mM.
[0049] In some examples of this embodiment, the volume ratio of platinum-gold nanorods to ferric chloride hexahydrate methanol solution and ligand solution is 1:1-5:1-5.
[0050] In some examples of this embodiment, the heating reaction has a heating temperature of 40-60°C, preferably 50°C; and a reaction time of 1-6h, preferably 1h, 1.5h, 2h, 3h, 6h.
[0051] Another typical embodiment of the present invention provides a platinum-gold nanorods@MOF composite material prepared by the preparation method of the above-mentioned platinum-gold nanorods@MOF composite material.
[0052] In some examples of this embodiment, the size of the platinum-gold nanorods@MOF composite material is 110-130 nm.
[0053] Platinum-gold nanorods have efficient plasma-induced electron-hole distribution and exhibit excellent NIR-II photothermal performance. MOF materials can catalyze endogenous hydrogen peroxide in tumors to produce toxic hydroxyl radicals to inhibit the proliferation of tumor cells.
[0054] The platinum-gold nanorod@MOF composite material of the present invention has good stability in aqueous solution, and the MOF shell can be responsively degraded in phosphate solution, and the released iron ions catalyze endogenous hydrogen peroxide to produce reactive oxygen to kill cancer cells through the Fenton effect. At the same time, the platinum-gold nanorod@MOF composite material has a high absorption capacity in the NIR-II region, and utilizes the synergistic effect of laser-activated O2 supply and photothermal enhancement to further improve the efficiency of catalytic cancer treatment.
[0055] A third typical embodiment of the present invention provides the use of the above-mentioned platinum-gold nanorods@MOF composite material in the preparation of photothermal and chemokinetic synergistic cancer-related drugs.
[0056] In some examples of this embodiment, the drug includes a nanotherapeutic agent and a photothermal agent.
[0057] In order to enable those skilled in the art to more clearly understand the technical solution of the present invention, the technical solution of the present invention will be described in detail below in conjunction with specific embodiments.
[0058] Example 1
[0059] A method for preparing a platinum-gold nanorod@MOF composite material comprises the following steps:
[0060] (1) Preparation of gold nanorods by seed method;
[0061] Seed solution: prepare 10 mL of 0.1 M hexadecyltrimethylammonium bromide (CTAB) aqueous solution, add 250 μL of 0.01 M chloroauric acid solution while stirring, quickly add 610 μL of 0.01 M glacial sodium borohydride solution, stir vigorously for 30 seconds, and then place in a 27°C water bath for 30 minutes to age to obtain a seed solution.
[0062] Growth solution: Weigh 3.6 g CTAB and 0.44 g 5-bromosalicylic acid, add 100 mL ultrapure water, and stir in a 55°C water bath until completely dissolved; add 2.4 mL 0.01 M silver nitrate aqueous solution, mix well, then add 100 mL 1 mM chloroauric acid solution, and stir again; add 510 μL 0.1 M L-ascorbic acid solution dropwise to the solution, and stir vigorously until the solution becomes colorless.
[0063] 320 μL of seed solution was added to the growth solution, and the mixture was reacted in a water bath at 27° C. in the dark for 12 hours to obtain gold nanorods.
[0064] (2) Take 10 mL of the gold nanorods obtained in step (1), add 0.568 mL of 0.1 M ascorbic acid solution, 0.099 mL of 0.01 M chloroplatinic acid solution and 0.08 mL of 0.01 M dilute hydrochloric acid thereto in sequence, stir evenly and place at 27° C. for 12 h to obtain platinum-gold nanorods.
[0065] (3) After washing by centrifugation, 20 mL of platinum-gold nanorods were redispersed in methanol, 40 mL of 7.5 mM ferric chloride hexahydrate methanol solution was added and stirred vigorously for 15 minutes, and then 40 mL of 7.5 mM benzenetricarboxylic acid methanol solution was added and stirred for another 15 minutes; the mixture was transferred to a 50°C oil bath for reaction for 1.5 h, and the reaction product was collected by multiple centrifugation to obtain a platinum-gold nanorod@MOF composite material.
[0066] Example 2
[0067] A method for preparing a platinum-gold nanorod@MOF composite material comprises the following steps:
[0068] (1) Preparation of gold nanorods by seed method;
[0069] Seed solution: prepare 10 mL of 0.1 M hexadecyltrimethylammonium bromide (CTAB) aqueous solution, add 250 μL of 0.01 M chloroauric acid solution while stirring, quickly add 610 μL of 0.01 M glacial sodium borohydride solution, stir vigorously for 30 seconds, and then place in a 27°C water bath for 30 minutes to age to obtain a seed solution.
[0070] Growth solution: Weigh 3.6 g CTAB and 0.44 g 5-bromosalicylic acid, add 100 mL ultrapure water, and stir in a 55°C water bath until completely dissolved; add 2.88 mL 0.01 M silver nitrate aqueous solution, mix well, then add 100 mL 1 mM chloroauric acid solution, and stir again; add 510 μL 0.1 M L-ascorbic acid solution dropwise to the solution, and stir vigorously until the solution becomes colorless.
[0071] 320 μL of seed solution was added to the growth solution, and the mixture was reacted in a water bath at 27° C. in the dark for 12 hours to obtain gold nanorods.
[0072] (2) Take 20 mL of the gold nanorods obtained in step (1), add 2.25 mL of 0.1 M ascorbic acid solution, 0.3 mL of 0.01 M chloroplatinic acid solution and 0.16 mL of 0.01 M dilute hydrochloric acid thereto in sequence, stir evenly and let stand at 30° C. for 12 h to obtain platinum-gold nanorods.
[0073] (3) After washing by centrifugation, 40 mL of platinum-gold nanorods were redispersed in methanol, 40 mL of 7.5 mM ferric chloride hexahydrate methanol solution was added and stirred vigorously for 15 minutes, and then 40 mL of 7.5 mM benzenetricarboxylic acid methanol solution was added and stirred for another 15 minutes; the mixture was transferred to a 50°C oil bath for reaction for 1.5 hours, and the reaction product was collected by multiple centrifugation to obtain a platinum-gold nanorod@MOF composite material.
[0074] Example 3
[0075] A method for preparing a platinum-gold nanorod@MOF composite material comprises the following steps:
[0076] (1) Preparation of gold nanorods by seed method;
[0077] Seed solution: prepare 10 mL of 0.1 M hexadecyltrimethylammonium bromide (CTAB) aqueous solution, add 250 μL of 0.01 M chloroauric acid solution while stirring, quickly add 610 μL of 0.01 M glacial sodium borohydride solution, stir vigorously for 30 seconds, and then place in a 27°C water bath for 30 minutes to age to obtain a seed solution.
[0078] Growth solution: Weigh 3.6 g CTAB and 0.44 g 5-bromosalicylic acid, add 100 mL ultrapure water, and stir in a 55°C water bath until completely dissolved; add 2.4 mL 0.01 M silver nitrate aqueous solution, mix well, then add 100 mL 1 mM chloroauric acid solution, and stir again; add 510 μL 0.1 M L-ascorbic acid solution dropwise to the solution, and stir vigorously until the solution becomes colorless.
[0079] 320 μL of seed solution was added to the growth solution, and the mixture was reacted in a water bath at 27° C. in the dark for 12 hours to obtain gold nanorods.
[0080] (2) Take 20 mL of the gold nanorods obtained in step (1), add 2.25 mL of 0.1 M ascorbic acid solution, 0.3 mL of 0.01 M chloroplatinic acid solution and 0.16 mL of 0.01 M dilute hydrochloric acid thereto in sequence, stir evenly and place at 30° C. for 24 h to obtain platinum-gold nanorods.
[0081] (3) After washing by centrifugation, 20 mL of platinum-gold nanorods were redispersed in methanol, 40 mL of 7.5 mM ferric chloride hexahydrate methanol solution was added and stirred vigorously for 15 minutes, and then 40 mL of 7.5 mM benzenetricarboxylic acid methanol solution was added and stirred for another 15 minutes; the mixture was transferred to a 60°C oil bath for reaction for 1.5 hours, and the reaction product was collected by multiple centrifugation to obtain a platinum-gold nanorod@MOF composite material.
[0082] Comparative Example 1
[0083] The preparation of MOF materials includes the following steps:
[0084] In 20 mL of methanol, add 40 mL of 7.5 mM ferric chloride hexahydrate methanol solution and stir vigorously for 15 minutes, then add 40 mL of 7.5 mM benzenetricarboxylic acid methanol solution and continue stirring for 15 minutes; transfer the mixture to a 50°C oil bath to react for 1.5 hours, and collect the reaction products by multiple centrifugation to obtain a MOF composite material.
[0085] Figure 1 This is a scanning electron microscope image of the platinum-gold nanorod@MOF composite material prepared in Example 1. It can be seen that the prepared nanoparticles have good dispersion and uniform size, and the average particle size is about 120 nm.
[0086] Figure 2 The X-ray diffraction patterns of the platinum-gold nanorods and platinum-gold nanorods@MOF composite materials in Example 1 and the MOF materials prepared in Comparative Example 1 are shown in Table 1. The coincidence of the corresponding characteristic peaks proves that the platinum-gold nanorods
[0087] @Successful preparation of MOF composite materials.
[0088] Figure 3 The figure shows the photothermal performance test of the platinum-gold nanorod@MOF composite material prepared in Example 1. Through calculation, it can be known that the photothermal conversion efficiency of the nanocomposite is as high as 70%.
[0089] The Pt-Au nanorods@MOF solution (100 μg / mL), H2O2 solution (2 mM), and TMB solution (1 mM) were mixed, and the generated ROS were detected once per minute using a UV-visible spectrophotometer. Figure 4 The graph shows the time-dependent absorbance (655 nm) variation of the platinum-gold nanorods@MOF composite material prepared in Example 1, catalyzing the oxidation of TMB to oxTMB in the presence of hydrogen peroxide, proving that the platinum-gold nanorods@MOF composite material has a Fenton catalytic effect.
[0090] The density is 2.5×10 3 / 100μL (per well) of K7M2 cells were inoculated in a 96-well plate and cultured at 37°C for 24h. After the cells adhered, 100μL of medium containing different concentrations of materials was replaced and incubated for another 12h. The medium was removed, washed three times with PBS, and then the cytotoxicity was tested with CCK-8, and the cell survival rate was calculated by the absorbance value at 450nm. Figure 5The CCK-8 toxicity study of the platinum-gold nanorods@MOF composite material prepared in Example 1 after incubation with K7M2 tumor cells for 6h, 12h, and 24h, respectively. As can be seen from the figure, with the increase of incubation time and material concentration, the inhibitory effect of the platinum-gold nanorods@MOF composite material on tumor cells is more obvious.
[0091] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A method for preparing a platinum-gold nanorod@MOF composite material, characterized in that: The steps include: (1) Preparing gold nanorods by the seed growth method, adding ascorbic acid solution, platinum salt solution and dilute hydrochloric acid to the obtained gold nanorods in sequence, mixing them well and leaving them in a water bath overnight to obtain platinum-gold nanorods; The platinum salt is chloroplatinic acid, potassium chloroplatinate or potassium chloroplatinite; (2) Washing the platinum-gold nanorods by centrifugation, dispersing them in methanol, adding a methanol solution of ferric chloride hexahydrate and stirring vigorously, and then adding a ligand solution and continuing to stir; heating the mixture to react, and collecting the product by centrifugation after the reaction is completed, thereby obtaining a platinum-gold nanorod@MOF composite material; The ligand is 2-aminoterephthalic acid or trimesic acid; the concentration of the ligand solution is 5-10 mM; The concentration of the ferric chloride hexahydrate methanol solution is 5-10 mM; The volume ratio of platinum-gold nanorods to ferric chloride hexahydrate methanol solution and ligand solution is 1:1-5:1-5; The platinum-gold nanorod@MOF composite material has a platinum-gold nanorod heterostructure that absorbs in the near-infrared II region, and a MOF structure with a Fenton effect is in situ assembled on its surface; The seed growth method is specifically as follows: Adding chloroauric acid solution to hexadecyltrimethylammonium bromide (CTAB) solution, then quickly adding glacial sodium borohydride solution, and aging at room temperature to obtain a seed solution; In the mixed solution of CTAB and stabilizer, silver nitrate solution and chloroauric acid solution are added successively, and after being stirred evenly, ascorbic acid solution is added to obtain a growth solution; Adding the seed solution to the growth solution and leaving it to stand overnight at room temperature to obtain gold nanorods; In the growth solution, the stabilizer is sodium oleate, 5-bromosalicylic acid, 2,6-dihydroxybenzoic acid or 4-methylsalicylic acid.
2. The method for preparing the platinum-gold nanorod@MOF composite material according to claim 1, characterized in that: In the seed solution, the concentration of the CTAB solution is 0.1-0.5M; the concentration of the chloroauric acid solution is 0.01-0.05M; the concentration of the sodium borohydride solution is 0.01-0.05M; The volumes of CTAB solution, chloroauric acid solution and glacial sodium borohydride solution are 10:0.2-0.5:0.5-1.
0.
3. The method for preparing the platinum-gold nanorod@MOF composite material according to claim 2, characterized in that: In the seed solution, the concentration of the CTAB solution is 0.1 M; the concentration of the chloroauric acid solution is 0.01 M; The concentration of the glacial sodium borohydride solution is 0.01M.
4. The method for preparing the platinum-gold nanorod@MOF composite material according to claim 1, characterized in that: In the growth solution, the CTAB concentration in the CTAB and stabilizer mixed solution is 30-50 mg / mL, and the stabilizer concentration is 3-5 mg / mL; the silver nitrate solution concentration is 0.01-0.05 M; the chloroauric acid solution concentration is 1-5 mM; and the ascorbic acid solution concentration is 0.1-0.5 M; The volume ratio of the mixed solution of CTAB and stabilizer to the silver nitrate solution, chloroauric acid solution and ascorbic acid solution is 100:1-5:100:0.1-0.7; The volume ratio of silver nitrate solution to seed solution is 7.5-10.5:
1.
5. The method for preparing the platinum-gold nanorod@MOF composite material according to claim 4, characterized in that: In the growth solution, the concentration of the silver nitrate solution is 0.01M; the concentration of the chloroauric acid solution is 1mM; and the concentration of the ascorbic acid solution is 0.1M.
6. The method for preparing the platinum-gold nanorod@MOF composite material according to claim 1, characterized in that: In step (1), the concentration of the ascorbic acid solution is 0.1-0.5M; the concentration of the platinum salt solution is 0.01-0.03M; and the concentration of the dilute hydrochloric acid is 0.01-0.05M; The volume ratio of the gold nanorods to the ascorbic acid solution, the platinum salt solution and the dilute hydrochloric acid solution is 10:0.2-2:0.01-0.2:0.01-0.
1.
7. The method for preparing the platinum-gold nanorod@MOF composite material according to claim 6, characterized in that: In step (1), the concentration of the ascorbic acid solution is 0.1 M; the concentration of the platinum salt solution is 0.01 M; and the concentration of the dilute hydrochloric acid is 0.01 M.
8. The method for preparing the platinum-gold nanorod@MOF composite material according to claim 1, characterized in that: The water bath has a temperature of 27°C-33°C.
9. The method for preparing the platinum-gold nanorod@MOF composite material according to claim 1, characterized in that: The heating reaction has a heating temperature of 40-60°C.
10. The method for preparing the platinum-gold nanorod@MOF composite material according to claim 9, characterized in that: The heating temperature is 50°C and the reaction time is 1-6h.
11. A platinum-gold nanorod@MOF composite material obtained by the preparation method of the platinum-gold nanorod@MOF composite material according to any one of claims 1 to 10.
12. The platinum-gold nanorod@MOF composite material according to claim 11, characterized in that: The size of the platinum-gold nanorod@MOF composite material is 110-130nm.
13. Use of the platinum-gold nanorod@MOF composite material according to claim 11 in the preparation of drugs related to photothermal and chemokinetic synergistic treatment of cancer.
14. Use of the platinum-gold nanorod@MOF composite material according to claim 13 in the preparation of drugs for photothermal and chemokinetic synergistic treatment of cancer, characterized in that: The drugs include nano-therapeutic agents and photothermal agents.
